Mira Jung - Aug 29, 2022 Form 3 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Role: Chief Scientific Officer
Signature: /s/ Mira Jung
Stock symbol: SHPH
Transactions as of: Aug 29, 2022
Transactions value $: $0
Form type: 3
Date filed: 9/7/2022, 09:21 AM
Next filing: Jan 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SHPH	COMMON STOCK						1.07M	Aug 29, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The undersigned became a Reporting Person subject to Section 16 reporting on August 29, 2022 at the time Shuttle Pharmaceuticals Holdings, Inc ("Company") completed its initial public offering ("IPO"). At the time of the IPO, the Reporting Person was the beneficial owner of 1,071,716 shares of common stock of the Company, consisting of (i) 1,070,824 shares of common stock and (ii) 892 restricted stock units ("RSUs"), of which 595 RSUs have fully vested and 297 RSUs remain subject to vesting.

Content

The undersigned became a Reporting Person subject to Section 16 reporting on August 29, 2022 at the time Shuttle Pharmaceuticals Holdings, Inc ("Company") completed its initial public offering ("IPO"). At the time of the IPO, the Reporting Person was the beneficial owner of 1,071,716 shares of common stock of the Company, consisting of (i) 1,070,824 shares of common stock and (ii) 892 restricted stock units ("RSUs"), of which 595 RSUs have fully vested and 297 RSUs remain subject to vesting.